Investigating genetic factors of multiple myeloma in African Americans
Comprehensive Investigation of Multiple Myeloma Genetic Susceptibility in African Americans
This study is looking at how genes might make some African Americans more likely to develop multiple myeloma, a type of blood cancer, so we can find better ways to prevent and treat it for those who are affected.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10925320 on NIH RePORTER |
What this research studies
This research focuses on understanding the genetic factors that contribute to multiple myeloma, a type of blood cancer, particularly in African Americans who are diagnosed at higher rates than other populations. The study will utilize advanced genetic and transcriptomic data analysis to identify genes that may increase susceptibility to this disease. By examining a large group of African American patients and controls, the research aims to uncover biological pathways that could lead to better prevention and treatment strategies tailored for this population.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American individuals who are at risk for or diagnosed with multiple myeloma.
Not a fit: Patients who are not of African descent or those without a diagnosis of multiple myeloma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and targeted therapies for multiple myeloma in African Americans.
How similar studies have performed: Previous research has shown promising results in understanding genetic factors in cancer susceptibility, making this approach both relevant and potentially impactful.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Kachuri, Mirlinda — Stanford University
- Study coordinator: Kachuri, Mirlinda
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.